
Calcium Alpha-Ketoglutarate (Ca-AKG) Powder
| Product Name | Calcium Alpha-Ketoglutarate Powder |
| CAS Number | 71686-01-6 |
| Appearance | White to off-white crystalline powder |
| Purity | ≥ 99.0% (by HPLC) |
| Packaging | 1 kg/bag, 5 kg/bag, 25 kg/drum |
| MOQ | 1 kg |
Bulk Calcium Alpha-Ketoglutarate Powder for Advanced Supplement Formulations
Crystalline morphology and moisture-sensitive flow behavior of bulk Calcium Alpha-Ketoglutarate Powder dictate die-fill uniformity and tableting speed in commercial-scale CMO operations. This physical profile directly impacts production uptime and scrap rates, making particle engineering a primary procurement criterion. Batch-specific HPLC fingerprinting and validated particle size distribution protocols provide the technical backbone for guaranteeing lot-to-lot consistency across multi-ton supply agreements. Controlling these powder attributes enables brand owners to differentiate finished products in a crowded longevity market, securing formulation exclusivity and premium pricing margins.
Commercial Demand Surge Drives the Ca-AKG Ingredient Market Expansion
The global Calcium Alpha-Ketoglutarate ingredient market at the raw-material layer is expanding at 7.2% CAGR, with finished supplements at 10.1%, driven by biohacker and aging-population demand for cellular energy and longevity formulations. The compound is transitioning from niche research chemical to mainstream formulation staple, led by North America and Europe.
- Biohacker target demographic: Ca-AKG resonates strongly with the quantified-self community, particularly consumers following Dr. Sinclair's longevity protocols. This segment demands high-purity, third-party-tested bulk powders for DIY capsule-filling or stack customization.
- Longevity SKU proliferation: Market data indicates that Ca-AKG is rapidly gaining recognition within longevity-focused product lines, with brands increasingly positioning it alongside NAD+ enhancers and spermidine. The growth is underpinned by clinical protocols like the ABLE trial.
- Formulation flexibility demand: The ingredient's compatibility with both capsule and powder delivery systems makes it versatile for longevity-focused brands. Its stable crystalline form also allows for clean-label positioning without flow aids.
For procurement directors, this demand surge requires a reliable Calcium Alpha-Ketoglutarate Powder supplier with documented batch-to-batch consistency in particle size distribution and moisture below 5% for high-speed filling lines.
US GRAS Status Establishes the Regulatory Backbone for Market Entry
AKG (free acid) is listed as an Old Dietary Ingredient (ODI) in the U.S., while Calcium Alpha-Ketoglutarate completed Self-GRAS scientific evaluation under FDA guidelines in January 2026. This qualification provides a pathway for incorporating the ingredient into dietary supplements without filing a new dietary ingredient notification (NDI).
| Region | Regulatory Status | Key Restriction / Daily Intake |
|---|---|---|
| United States | AKG: ODI listed / Ca-AKG: Self-GRAS (2026) | No specific ADI limit; safety confirmed at up to 6 g/day |
| European Union | Novel Food classification for certain AKG salts | Ca-AKG status: further verification required |
| Global Trade | Food Grade / Nutritional Grade | Heavy metals (internal control): Pb ≤ 2.0 mg/kg, As ≤ 1.0 mg/kg |
This Self-GRAS dossier, backed by clinical safety data at up to 4.5 g/day over three years in specific patient populations and the ABLE trial's 1 g/day parameters, provides a compliance foundation for brand owners seeking wholesale Calcium Alpha-Ketoglutarate Powder for longevity-positioned SKUs without individualized FDA determinations. Maintaining documented impurity controls at sub-ppm levels not only satisfies US requirements but also preemptively addresses EU and other major market thresholds, thereby shortening port-of-entry inspection cycles and reducing regulatory hold risks.
Source Purity Differentiation: Processing Routes and Impurity Profiles of Bulk Calcium Alpha-Ketoglutarate Powder Raw Material
Bulk Ca-AKG is manufactured via a two-stage industrial process: upstream fermentation of alpha-ketoglutaric acid followed by aqueous-phase neutralization and crystallization. The upstream stage employs microbial fermentation—using strains such as Yarrowia lipolytica or Corynebacterium glutamicum on glucose or glycerol substrates—to produce the free acid. The downstream stage neutralizes this acid with calcium hydroxide or carbonate in aqueous medium, then concentrates, crystallizes, centrifuges, and dries to yield stable crystalline powder (U.S. Pat. No. 11,802,103).
- Fermentation-derived acid with documented yield: Industrial strains such as Yarrowia lipolytica have demonstrated alpha-ketoglutarate accumulation; a 2025 study reported 117.7 g/L from crude glycerol, providing a bio-based source with low organic solvent exposure prior to neutralization.
- Aqueous-phase crystallization and solvent control: Neutralization with calcium hydroxide followed by controlled crystallization minimizes Class 1 and Class 2 organic solvent risks. Adherence to USP <467> residual solvent limits—particularly for ethanol and ethyl acetate—differentiates ≥99.0% Calcium Alpha-Ketoglutarate Powder for clean-label markets.
- Chromatographic verification of source integrity: Reverse-phase HPLC with ICP-MS heavy metal profiling (Pb, As, Cd, Hg at sub-ppm limits) enables buyers to verify processing route consistency and flag deviations before batch acceptance.
Suppliers providing complete impurity profiles, residual solvent panels, and transparent source documentation enable procurement teams to audit manufacturing authenticity and safeguard brand equity across regulated markets.
TCA Cycle Mechanism and ABLE Trial Parameters for Bulk Calcium Alpha-Ketoglutarate Powder
Ca-AKG functions as a tricarboxylic acid (TCA) cycle intermediate, supporting cellular ATP generation, amino acid synthesis, and epigenetic regulation—all processes implicated in biological aging (Trends Endocrinol Metab, 2022; doi: 10.1016/j.tem.2021.11.003). Its calcium salt form provides a near-neutral buffered range (6.0-8.0 in 1% solution) alternative to free AKG acid (pH 2-3), enabling direct incorporation into standard capsules without enteric coatings.
- mTOR and autophagy modulation: Ca-AKG participates in nutrient-sensing pathways that regulate cellular maintenance and protein homeostasis. This mechanism supports its inclusion in formulations targeting age-related metabolic decline and tissue integrity.
- Clinical trial parameters: The ABLE recruitment evaluation of Calcium Alpha-Ketoglutarate Powder raw material reports a double-blind RCT administering 1 g/day sustained-release Ca-AKG to 120 adults aged 40-60 for 6 months plus 3-month follow-up, with PhenoAge DNA methylation as the primary endpoint and inflammatory, muscle, arterial, cognitive, and metabolic measures as secondary endpoints (Experimental Gerontology, 2025; doi: 10.1016/j.exger.2025.112867).
- Enhanced solid-state stability: Ca-AKG powder exhibits extended shelf life compared to free acid forms, with less than 3% degradation observed under accelerated stability conditions (40°C / 75% RH over six months) in sustained-release prototypes.
- Direct formulation compatibility: The buffered pH and crystalline morphology of Ca-AKG eliminate the need for acid-neutralizing buffers or specialized coating equipment, reducing both raw material costs and production complexity.
This trial framework gives brand owners seeking a Calcium Alpha-Ketoglutarate Powder supplier a documented dose and population reference; aligning formulation dosage with the ABLE trial's 1 g/day arm lets developers sourcing wholesale Calcium Alpha-Ketoglutarate Powder ≥99.0% use the same parameters as a claim-development reference, without implying efficacy.
Combinatorial Formulation Synergies and Compatibility Mapping
Ca-AKG demonstrates strong pairing compatibility with NAD+ precursors such as nicotinamide mononucleotide powder and nicotinamide riboside, alongside autophagy-supporting spermidine trihydrochloride powder and senolytic flavonoids including fisetin powder and quercetin—enabling multi-target longevity formulations. Its crystalline powder form, featuring ≥ 95% through 80 mesh and loss on drying ≤ 5.0%, processes cleanly with these co-ingredients without clumping.
| Co-Ingredient | Synergistic Target | Formulation Compatibility Note |
|---|---|---|
| NAD+ precursors (NMN/NR) | Dual support for cellular energy + DNA repair | Compatible in HPMC capsules; avoid high shear mixing which may degrade NR |
| Spermidine | Autophagy + mTOR pathway synergy | Both are stable in dry blends; moisture content below 5% critical |
| Fisetin / Quercetin | Senolytic + metabolic support | Monitor pH shifts; Ca-AKG buffering capacity helps stabilize flavonoid degradation |
For CMO production planning, the excipient-free capsule format is viable due to the powder's inherent flowability and compressibility. At a 500 mg capsule fill weight, the 95% through 80 mesh particle size ensures uniform die filling, reducing weight variation and scrap rates during high-speed encapsulation runs.
Secure Technical Samples for Formulation Feasibility Verification
This ingredient's documented particle size specification (≥ 95% through 80 mesh) and moisture control (≤ 5.0% LOD) directly translate into production predictability—reducing CMO adjustment time, minimizing die wear, and preventing flow-related machine stoppages. For R&D teams, the availability of batch-specific HPLC fingerprints and impurity profiles accelerates feasibility assessment and supplier approval workflows. A total-cost-of-ownership audit reveals that selecting this controlled-morphology grade eliminates downstream rework expenses and protects against cross-border logistics-induced caking, ensuring delivered containers match the original COA.
Request a spec-verified Ca-AKG sample with complete COA packages to validate its performance on your specific production equipment.
Frequently Asked Questions
Related Products
Request a Quote for Calcium Alpha-Ketoglutarate (Ca-AKG) Powder
Tell us your required quantity and application. Our team will help you evaluate product specifications, pricing, samples, and supply options.
